HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacogenomic and molecular docking studies on the cytotoxicity of the natural steroid wortmannin against multidrug-resistant tumor cells.

Abstract
Wortmannin is a cytotoxic compound derived from the endophytic fungi Fusarium oxysporum, Penicillium wortmannii and Penicillium funiculosum that occurs in many plants, including medicinal herbs. The rationale to develop novel anticancer drugs is the frequent development of tumor resistance to the existing antineoplasic agents. Therefore, it is mandatory to analyze resistance mechanisms of novel drug candidates such as wortmannin as well to bring effective drugs into the clinic that have the potential to bypass or overcome resistance to established drugs and to substantially increase life span of cancer patients. In the present project, we found that P-glycoprotein-overexpressing tumor cells displaying the classical multidrug resistance phenotype toward standard anticancer drugs were not cross-resistant to wortmannin. Furthermore, three point-mutated PIK3CA protein structures revealed similar binding energies to wortmannin than wild-type PIK3CA. This protein is the primary target of wortmannin and part of the PI3K/AKT/mTOR signaling pathway. PIK3CA mutations are known to be associated with worse response to therapy and shortened its activity toward wild-type and mutant PIK3CA with similar efficacy.
AuthorsVictor Kuete, Mohamed E M Saeed, Onat Kadioglu, Jonas Börtzler, Hassan Khalid, Henry Johannes Greten, Thomas Efferth
JournalPhytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine) Vol. 22 Issue 1 Pg. 120-7 (Jan 15 2015) ISSN: 1618-095X [Electronic] Germany
PMID25636880 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014. Published by Elsevier GmbH.
Chemical References
  • ABCB1 protein, human
  • ATP Binding Cassette Transporter, Subfamily B
  • Androstadienes
  • Antineoplastic Agents
  • Phosphatidylinositol 3-Kinases
  • Class I Phosphatidylinositol 3-Kinases
  • PIK3CA protein, human
  • Wortmannin
Topics
  • ATP Binding Cassette Transporter, Subfamily B (metabolism)
  • Androstadienes (pharmacology)
  • Antineoplastic Agents (pharmacology)
  • Cell Line, Tumor
  • Class I Phosphatidylinositol 3-Kinases
  • Cluster Analysis
  • Drug Resistance, Multiple
  • Drug Resistance, Neoplasm (drug effects)
  • Humans
  • Molecular Docking Simulation
  • Oligonucleotide Array Sequence Analysis
  • Pharmacogenetics
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Signal Transduction (drug effects)
  • Wortmannin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: